Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice

British Journal of Dermatology

Volumn 144, Issue 6, 2001, Pages 1207-1214

  Sharfaei, S ^a   Viau, G ^a   Lui, H ^a   Bouffard, D ^b   Bissonnette, R ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Photocarcinogenesis; Protoporphyrin IX; Skin cancer; Squamous cell carcinoma; Ultraviolet radiation

Indexed keywords

AMINOLEVULINIC ACID;

ACTINIC KERATOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLUORESCENCE MICROSCOPY; MORTALITY; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SKIN TUMOR; SPECTROFLUOROMETRY; ULTRAVIOLET RADIATION;

ANIMALS; DISEASE-FREE SURVIVAL; FEMALE; MICE; MICE, INBRED HRS; MICROSCOPY, FLUORESCENCE; NEOPLASMS, RADIATION-INDUCED; PHOTOCHEMOTHERAPY; SKIN; SKIN NEOPLASMS; SPECTROMETRY, FLUORESCENCE; ULTRAVIOLET RAYS;

EID: 0035724538     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04232.x     Document Type: Article

References (29)

1. The epidemiology of skin cancer
2. Current status of photodynamic therapy in dermatology
3. Photodynamic therapy with endogenous protoporphyrin IX. Basic principles and present clinical experience
4. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?
5. Photodynamic therapy of actinic keratosis with topical 5-aminolaevulinic acid
6. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine
7. Superficial photo-dynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer
8. Repetitive photodynamic therapy with topical delta-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors
9. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolaevulinic acid sensitization and laser irradiation
10. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photo-carcinogenesis in hairless mice
11. Photobiology 102: UV sources and dosimetry - The proper use measurement of 'photons as a reagent'
12. UV-induced skin cancer in a hairless mouse model
13. Development of skin tumours in hairless mice after discontinuation of ultraviolet irradiation
14. Oral delta-aminolaevulinic acid induces full-thickness protoporphyrin IX fluorescence in basal cell carcinoma
15. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolaevulinic acid: Implications for photodynamic treatment
16. In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster
17. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolaevulinic acid in mice bearing mammary carcinoma
18. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model
19. Photosensitization of murine tumor, vasculature and skin by 5-amino-levulinic acid-induced porphyrin
20. Effectiveness of delta-aminolaevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo
21. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: Increased damage after multiple irradiations
22. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence
23. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats
24. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA)
25. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX
26. On-line fluorescence of human tissues after oral administration of 5-aminolevulinic acid
27. Pharmacokinetics of 5-amino-levulinic acid-induced protoporphyrin IX in skin and blood
28. Tumour blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans
29. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo